Abstract
Purpose. To investigate the hypothesis that faster drug absorption from a new paracetamol formulation containing sodium bicarbonate compared to that from a conventional formulation results from a combination of enhanced gastric emptying and disintegration/dissolution.
Methods. Each formulation was administered in both fasted and fed states to 12 healthy volunteers. Gastric emptying and disintegration times were assessed by γ scintigraphy, and serum paracetamol concentrations were determined by HPLC.
Results. The mean time to complete disintegration of the new tablets was faster than that for conventional tablets in both fasted (10.2 min vs. 22.5 min) and fed (14.3 min vs. 46.4 min) states, although this difference was statistically significant in the fed state only (p = 0.0053). Mean gastric emptying times for the new tablets, as measured by t50 and t90, were also faster than those for conventional tablets in both fasted (t50 = 22.4 min vs. 47.5 min, t90 = 30.9 min vs. 64.1 min) and fed (t50 = 76.9 min vs. 106.4 min, t90 = 152.7 min vs. 155.5 min) states, although these differences were not statistically significant. Two subjects showed dramatically retarded gastric emptying of the new tablets in the fasted state: if these atypical data are excluded, the differences in both t50 and t90 in the fasted state are significant (p = 0.0110 and 0.0035, respectively). Rate of paracetamol absorption reflected the gastric emptying profiles as shown by significant correlation of emptying times with partial AUC.
Conclusions. It would seem that a combination of faster disintegration and gastric emptying of the new tablets is responsible for the faster rate of absorption of paracetamol from PA compared to P observed in both this study and in previous studies. The differences in gastric emptying are more pronounced in the fasted state, and the differences in disintegration are more pronounced in the fed state.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
L. F. Prescott. Paracetamol: past, present, and future. Am. J. Ther. 7:143-147 (2000).
L. Prescott. Paracetamol (Acetaminophen): A Critical Bibliographic Review, Taylor & Francis, London, 1996.
R. Heading, J. Nimmo, L. Prescott, and P. Tothill. The dependence of paracetamol absorption on the rate of gastric emptying. Br. J. Pharmacol. 47:415-421 (1973).
J. A. Clements, R. C. Heading, W. S. Nimmo, and L. F. Prescott. Kinetics of acetaminophen absorption and gastric emptying in man. Clin. Pharmacol. Ther. 24:420-431 (1978).
G. Paintaud, P. Thibault, P. E. Queneau, J. Magnette, M. Berard, L. Rumbach, P. R. Bechtel, and P. Carayon. Intraindividual variability of paracetamol absorption kinetics after a semi-solid meal in healthy volunteers. Br. J. Clin. Pharmacol. 53:355-359 (1998).
A. Rostami-Hodjegan, M. R. Shiran, R. Ayesh, T. J. Grattan, I. Burnett, A. Darby-Dowman, and G. T. Tucker. A new rapidly absorbed paracetamol tablet containing sodium bicarbonate. I. A four way crossover study to compare the concentration–time profile of paracetamol from the new paracetamol/sodium bicarbonate tablet and a conventional paracetamol tablet in fed and fasted volunteers. Drug Dev. Ind. Pharm. 28:523-531 (2002).
T. Grattan, R. Hickman, A. Darby-Dowman, M. Hayward, M. Boyce, and S. Warrington. A five way crossover human volunteer study to compare the pharmacokinetics of paracetamol following oral administration of two commercially available paracetamol tablets and three development tablets containing paracetamol in combination with sodium bicarbonate or calcium carbonate. Eur. J. Pharm. Biopharm. 49:225-229 (2000).
A. Rostami-Hodjegan, M. R. Shiran, G. T. Tucker, B. R. Conway, W. J. Irwin, L. R. Shaw, and T. J. Grattan. A new rapidly absorbed paracetamol tablet containing sodium bicarbonate. II. Dissolution studies and in vitro/in vivo correlation. Drug Dev. Ind. Pharm. 28:533-543 (2002).
J. N. Hunt and J. D. Pathak. The osmotic effects of some simple molecules and ions on gastric emptying. J. Physiol. 154:254-269 (1960).
L. R. Shaw, W. J. Irwin, T. J. Grattan, and B. R. Conway. Discriminatory dissolution testing for paracetamol formulations, British Pharmaceutical Conference, Pharmaceutical Press, Glasgow, 2001, p. 196.
J. W. Moore and H. H. Flanner. Mathematical comparison of curves with an emphasis on in-vitro dissolution profiles. Pharm. Tech. 20:64-74 (1996).
L. R. Shaw. The development of a novel in vitro model suitable for the prediction of bioavailability, School of Pharmaceutical and Biological Sciences, Aston University, Birmingham, 2001.
A. Wald, D. H. V. Thiel, L. Hoechstetter, J. S. Gavaler, K. M. Egler, R. Verm, L. Scott, and R. Lester. Gastrointestinal transit: the effect of the menstrual cycle. Gastroenterology 80:1497-1500 (1981).
L. P. Degen and S. F. Phillips. Variability of gastrointestinal transit in healthy women and men. Gut 39:299-305 (1996).
W. R. Hutson, R. L. Roehrkasse, and A. Wald. Influence of gender and menopause on gastric emptying and motility. Gastroenterology 96:11-17 (1989).
L. C. Knight, H. P. Parkman, K. L. Brown, M. A. Miller, D. M. Trate, A. H. Maurer, and R. S. Fisher. Delayed gastric emptying and decreased antral contractility in normal pre-menopausal women compared with men. Am. J. Gastroenterol. 92:968-975 (1997).
R. Khosla and S. S. Davis. Gastric emptying and small and large bowel transit of non-disintegrating tablets in fasted subjects. Int. J. Pharm. 52:1-10 (1989).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kelly, K., O'Mahony, B., Lindsay, B. et al. Comparison of the Rates of Disintegration, Gastric Emptying, and Drug Absorption Following Administration of a New and a Conventional Paracetamol Formulation, Using γ Scintigraphy. Pharm Res 20, 1668–1673 (2003). https://doi.org/10.1023/A:1026155822121
Issue Date:
DOI: https://doi.org/10.1023/A:1026155822121